To stop or not to stop disease modifying therapies in secondary progressive multiple sclerosis, that is the question

Research output: Contribution to journal › Editorial (Lead article) › Contributed › peer-review

Contributors

  • Emanuele D’Amico - , Ospedali Riuniti Villa Sofia-Cervello (Author)
  • Tjalf Ziemssen - , Department of Neurology (Author)
  • Salvatore Cottone - , Ospedali Riuniti Villa Sofia-Cervello (Author)

Details

Original languageEnglish
Pages (from-to)847-849
Number of pages3
JournalExpert review of neurotherapeutics
Volume17
Issue number9
Publication statusPublished - 2 Sept 2017
Peer-reviewedYes

External IDs

PubMed 28594298
ORCID /0000-0001-8799-8202/work/171553401

Keywords

ASJC Scopus subject areas

Keywords

  • DMT, Multiple sclerosis, outcome, secondary progressive multiple sclerosis, therapy